1. Home
  2. ACMR vs RCUS Comparison

ACMR vs RCUS Comparison

Compare ACMR & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACMR

ACM Research Inc.

HOLD

Current Price

$56.19

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$25.39

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACMR
RCUS
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
ACMR
RCUS
Price
$56.19
$25.39
Analyst Decision
Strong Buy
Buy
Analyst Count
1
10
Target Price
$50.00
$31.90
AVG Volume (30 Days)
981.0K
1.2M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.37
N/A
Revenue
$74,643,000.00
$247,000,000.00
Revenue This Year
$29.37
N/A
Revenue Next Year
$23.16
$45.62
P/E Ratio
$39.34
N/A
Revenue Growth
104.47
N/A
52 Week Low
$17.32
$7.06
52 Week High
$71.65
$28.72

Technical Indicators

Market Signals
Indicator
ACMR
RCUS
Relative Strength Index (RSI) 66.10 59.94
Support Level $49.37 $19.62
Resistance Level $70.56 N/A
Average True Range (ATR) 2.46 1.56
MACD 1.33 0.30
Stochastic Oscillator 93.01 61.22

Price Performance

Historical Comparison
ACMR
RCUS

About ACMR ACM Research Inc.

ACM Research Inc supplies capital equipment developed for the semiconductor industry. The company focuses on developing differentiated process solutions that enable effective particle removal, uniform material deposition, and reliable process control for the fabricators of integrated circuits. Its product offerings include wet-cleaning, plating, furnace, PECVD, track, and other front-end processing equipment. Additionally, it develops, manufactures, and sells a range of packaging equipment to wafer assembly and packaging customers. Geographically, the company generates maximum revenue from its customers in Mainland China, and the rest from other regions.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: